The webinar explored how economic evaluations guide decisions about funding robotic surgery. Using examples such as robotic prostatectomy, the speaker showed how differences in evidence quality, time horizons, and modeling approaches can dramatically change cost-effectiveness results. He outlined how costs, utilities, and Markov models are used to estimate value, emphasizing the influence of procedural volume, learning curves, and real-world evidence. The session reinforced that rigorous, transparent methods are essential to accurately judge whether robotics delivers sufficient long-term value to justify its high upfront costs.